Advertisement
Advertisement

SNWV

SNWV logo

SANUWAVE Health, Inc. Common Stock

8.61
USD
Sponsored
+0.98
+12.84%
Jun 26, 16:00 UTC -4
Closed
exchange

After-Market

8.71

+0.10
+1.14%

SANUWAVE Health, Inc. Common Stock Profile

About

SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.

Info & Links

CEO

Morgan Frank

Headquarters

9600 W. 76th St, Ste 118
Eden Prairie, MN 55344, UNITED STATES

Industry

Medical Products

Sector

Medical

Website

www.sanuwave.com

Auditor

Baker Tilly US, LLP

Share holders

159

Employees

55

SANUWAVE Health, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

74.88M

Enterprise Value

84.67M

Enterprise Value/EBITDA(ttm)

15.31

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

3.52

Price to Book(mrq)

96.20

Price to Cash(ytd)

10.70

Profitability

Gross Margin(ttm)

77.34%

Operating Margin(ttm)

26.64%

Profit Margin(ttm)

21.61%

Return on Equity(ttm)

-141.56%

Return on Invested Capital(ttm)

129.48%

Return on Assets(ttm)

34.53%

Income Statement

Revenue(ttm)

44.34M

Revenue Per Share(ttm)

5.16

Gross Profit(ttm)

34.02M

EBITDA(ttm)3

5.53M

Net Income Available to Common(ttm)

16.49M

Diluted EPS(ttm)

-0.16

Share Statistics

Beta (5Y Monthly)

1.51

52-Week Change

-73.83%

S&P 500 52-Week Change

19.75%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

8.60M

Dividend Yield

0.00%

Float4

7.31M

% Held by Insiders

14.90%

% Held by Institutions

42.53%

Balance Sheet

Total Cash(mrq)

10.78M

Total Cash Per Share(mrq)

1.25

Total Debt(mrq)

20.57M

Total Debt/Equity(mrq)

1356.39%

Current Ratio(mrq)

1.38%

Quick Ratio(mrq)

1.05%

Book Value Per Share(mrq)

0.19

Cash Flow

Operating Cash Flow Per Share(ytd)

0.43

Free Cash Flow(ytd)

7.31M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement